MGX

Metagenomi Therapeutics Inc

0.7747

Nov 11 • 9:41 AM ET +0.0747 (10.67%)

Healthcare Biotechnology USA Nano NASD

Nov 10, 5:31 PMMetagenomi wins FDA IND clearance for hemophilia A gene-editing candidate MGX-001 and reports Q3 2026 net loss $21.1M, or $0.56 per share, on $2.2M revenue

Peers: CRBU DTIL EDIT PRME NTLA BEAM CRSP LXEO PASG TSHA

| Held by: VTI VXF IWC BUSM

Scroll to Statements

Index	-
Market Cap	29.26M
Enterprise Value	-36.20M
Income	-94.19M
Sales	7.09M
Book/sh	2.46
Cash/sh	2.69
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	119
IPO	Feb 09, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	4.13
P/B	0.31
P/C	0.29
P/FCF	-
EV/EBITDA	-
EV/Sales	-5.11
Quick Ratio	3.43
Current Ratio	3.43
Debt/Eq	0.39
LT Debt/Eq	0.32
Option/Short	No / Yes

EPS (ttm)	-2.50
EPS next Y	-1.84
EPS next Q	-0.53
EPS this Y	-2.67%
EPS next Y	24.04%
EPS next 5Y	7.79%
EPS past 3/5Y	-26.57% -42.49%
Sales past 3/5Y	13.59% 219.15%
EPS Y/Y TTM	-5.97%
Sales Y/Y TTM	-77.08%
EPS Q/Q	-2.44%
Sales Q/Q	-74.78%
Earnings	Nov 10 AMC
EPS/Sales Surpr.	12.43% -15.18%

Insider Own	21.07%
Insider Trans	0.11%
Inst Own	16.26%
Inst Trans	-1.57%
ROA	-46.48%
ROE	-69.35%
ROIC	-76.56%
Gross Margin	28.11%
Oper. Margin	-1410.57%
Profit Margin	-1329.31%
SMA20	-1.09%
SMA50	-20.14%
SMA200	-38.34%
Trades

Shs Outstand	37.81M
Shs Float	29.82M
Short Float	4.46%
Short Ratio	8.56
Short Interest	1.33M
52W High	2.23 -65.26%
52W Low	0.60 29.12%
Volatility	12.45% 10.19%
ATR (14)	0.08
RSI (14)	41.98
Beta	0.84
Rel Volume	5.77
Avg Volume	155.25K
Volume	68,811

Perf Week	-1.94%
Perf Month	-15.55%
Perf Quarter	-37.02%
Perf Half Y	-43.86%
Perf YTD	-52.18%
Perf Year	-64.79%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.40
Target Price	7.00
Prev Close	0.70
Price	0.77
Change %	10.67%

Consensus

Strong Buy

Avg. Price Target

$7.00

Implied Upside

+803.6%

Analysts7incl. previous ratings

Rating Distribution6 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jul 07, 2026	Resumed	CChardan Capital Markets	Buy	$5	+545.4%
May 07, 2024	Initiated	HH.C. Wainwright	Buy	$10	+1,190.8%
May 02, 2024	Downgrade	JJP Morgan	Overweight → Neutral	$16 → $6	+674.5%
Mar 05, 2024	Initiated	WWells Fargo	Overweight	$25	+3,127.1%
Mar 05, 2024	Initiated	TTD Cowen	Outperform
Mar 05, 2024	Initiated	JJP Morgan	Overweight	$16	+1,965.3%
Mar 05, 2024	Initiated	JJefferies	Buy	$23	+2,868.9%
Mar 05, 2024	Initiated	CChardan Capital Markets	Buy	$21	+2,610.7%
Mar 05, 2024	Initiated	BBMO Capital Markets	Outperform	$22	+2,739.8%

Today 08:00AM	Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference in London (GlobeNewswire) +10.67%
Nov-10-26 05:14PM	Metagenomi Therapeutics: Q3 Earnings Snapshot (Associated Press)
04:05PM	Metagenomi Therapeutics Announces FDA Clearance of Investigational New Drug Application for MGX-001 and Reports Third Quarter 2026 Financial Results (GlobeNewswire)
Nov-04-26 09:25AM	Metagenomi Therapeutics to Present Preclinical Data Supporting MGX-001, a Potential One-Time Therapy for Hemophilia A, in Oral Presentation at 68th American Society of Hematology Annual Meeting (GlobeNewswire)
Oct-13-26 08:00AM	Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference (GlobeNewswire) -10.07%
08:00AM	Loading…
Sep-01-26 08:00AM	Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference (GlobeNewswire)
Aug-25-26 10:13AM	Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Aug-10-26 04:47PM	Metagenomi Therapeutics: Q2 Earnings Snapshot (Associated Press)
04:05PM	Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results (GlobeNewswire)
Jun-05-26 03:45PM	Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
May-28-26 08:00AM	Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-11-26 04:18PM	Metagenomi Therapeutics: Q1 Earnings Snapshot (Associated Press)
04:05PM	Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results (GlobeNewswire)
Apr-16-26 07:00AM	Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency (GlobeNewswire)
Apr-13-26 12:15PM	Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
05:30PM	Loading…
Mar-05-26 05:30PM	Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -8.07%
04:28PM	Metagenomi Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results (GlobeNewswire)
Feb-26-26 05:30PM	Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates (Zacks) -5.00%
Feb-23-26 04:05PM	Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference (GlobeNewswire) +6.38%
Jan-12-26 08:30AM	Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook (GlobeNewswire)
Dec-02-25 12:32PM	Amazon Launches New AI Chip While Teasing Future Tech Collaboration With Nvidia (Investor's Business Daily)
Dec-01-25 07:00AM	Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference (GlobeNewswire) -8.57%
Nov-17-25 08:00AM	Metagenomi to Present at Jefferies Global Healthcare Conference in London (GlobeNewswire)
Nov-12-25 05:20AM	Metagenomi, Ovid CEOs step aside; Cogent soars on unprecedented stomach cancer data (BioPharma Dive) -15.45%
Nov-11-25 05:10PM	Metagenomi (MGX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:09PM	Metagenomi: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates (GlobeNewswire)
04:01PM	Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development (GlobeNewswire)
Nov-10-25 05:45PM	KalVista Pharmaceuticals, Inc. (KALV) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:50AM	Loading…
Nov-06-25 08:50AM	Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Beat Estimates (Zacks)
Nov-05-25 05:35PM	Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Oct-22-25 10:02AM	Metagenomi taps Amazon's custom chips to develop gene-editing tools (Reuters) -8.57%
Oct-20-25 12:00PM	Here's Why Metagenomi (MGX) is a Great Momentum Stock to Buy (Zacks) +9.84%
Aug-12-25 05:40PM	Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:25PM	Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:37PM	Metagenomi: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-11-25 04:05PM	Metagenomi Appoints Laurence Reid, PhD to its Board of Directors (GlobeNewswire)
Aug-07-25 08:35AM	Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -8.57%
Jul-29-25 10:23AM	Metagenomi (MGX) Presents Latest in Gene Editing Technologies (Insider Monkey) -6.56%
Jul-18-25 10:06AM	BeOne Medicines Ltd. - Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains? (Zacks) -6.57%
09:41AM	Oracle's AI-driven surge: Can its stock rally last? (Yahoo Finance)
Jul-14-25 11:12AM	Metagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT Meeting (Insider Monkey)
May-14-25 06:00AM	Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 (GlobeNewswire) -6.25%
May-13-25 05:40PM	Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:42PM	Metagenomi: Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	Metagenomi Reports Business Updates and First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 09:30AM	NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +9.66%
May-06-25 07:15AM	Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -7.96%
May-02-25 07:00AM	Metagenomi to Present at Upcoming Scientific Meetings (GlobeNewswire) +8.05%
Apr-01-25 11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks)
Mar-17-25 04:05PM	Metagenomi Reports Business Updates and Full Year 2024 Financial Results (GlobeNewswire) -7.98%
Mar-13-25 06:19AM	Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems (GlobeNewswire) -6.83%
Feb-11-25 08:55AM	Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -6.17%
Jan-28-25 08:00AM	Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer (GlobeNewswire)
Jan-22-25 11:54AM	People are buying the wrong stock thinking it's part of OpenAI's Stargate Project (Quartz) +11.40%
Jan-16-25 08:55AM	Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones (GlobeNewswire)
Jan-15-25 08:55AM	Metagenomi Announces New Appointment to its Board of Directors (GlobeNewswire)
Jan-08-25 04:05PM	Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -6.36%
Dec-11-24 06:30PM	Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference RNA at the Bench and Bedside IV (GlobeNewswire) -5.73%
Dec-09-24 09:16PM	Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting (GlobeNewswire) +125.41%
Dec-08-24 06:05AM	Jefferies Predicts Up to ~1000% Surge for These 2 Strong Buy Stocks (TipRanks)
Nov-18-24 12:00PM	What Makes Metagenomi (MGX) a New Buy Stock (Zacks)
Nov-13-24 04:37PM	Metagenomi: Q3 Earnings Snapshot (Associated Press Finance) -10.90%
04:05PM	Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 04:05PM	Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting (GlobeNewswire)
Oct-29-24 05:45AM	Metagenomi, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX (PR Newswire)
Oct-24-24 08:04AM	Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT (GlobeNewswire)
Oct-23-24 05:45AM	Investors in Metagenomi, Inc. Should Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX (PR Newswire)
Oct-14-24 08:58PM	Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies (GlobeNewswire)
Oct-01-24 03:14PM	Metagenomi, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights - MGX (PR Newswire)
Sep-19-24 07:15PM	Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference (GlobeNewswire) -6.84%
Sep-03-24 04:05PM	Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months (GlobeNewswire)
Aug-29-24 07:32PM	Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference (GlobeNewswire)
Aug-28-24 06:10PM	Metagenomi to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.05%
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Metagenomi, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-14-24 08:11AM	Metagenomi: Q2 Earnings Snapshot (Associated Press Finance)
08:05AM	Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-12-24 06:29PM	Metagenomi, Inc. (MGX): This New Penny Stock Received a Positive Rating From Street Analysts (Insider Monkey) +10.54%
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Metagenomi and Encourages Investors to Contact the Firm (GlobeNewswire)
Jun-03-24 04:30PM	Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-29-24 04:00PM	Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-14-24 10:54PM	MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results (GlobeNewswire)
May-04-24 10:49AM	Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace) -12.36%
May-01-24 04:00PM	Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems (GlobeNewswire)
01:53PM	Moderna exits gene editing deal worth up to $3B biobucks, leaving Metagenomi in the spotlight (FierceBiotech.com)
Apr-08-24 08:00AM	Metagenomi to Present at Upcoming Scientific Meetings (GlobeNewswire)
Mar-27-24 09:16AM	Metagenomi Reports Business Updates and Full Year 2023 Financial Results (GlobeNewswire)
Feb-29-24 04:30PM	Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-13-24 04:35PM	Metagenomi Announces Closing of Initial Public Offering (GlobeNewswire)
Feb-08-24 10:16PM	Metagenomi Announces Pricing of Initial Public Offering (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Reid Laurence	Director	Sep 09 '26	Buy	1.17	20,000	23,401	20,000	Sep 11 07:51 PM
Wein Matthew	See Remarks	Sep 08 '26	Sale	1.16	358	415	126,133	Sep 10 03:47 PM
Irish Jian	See Remarks	Sep 08 '26	Sale	1.16	2,140	2,479	375,393	Sep 10 03:40 PM
Wapnick Pamela	Chief Financial Officer	Sep 08 '26	Sale	1.16	1,911	2,214	206,580	Sep 10 03:34 PM
Wapnick Pamela	Chief Financial Officer	Jun 05 '26	Sale	1.30	2,884	3,746	208,491	Jun 10 11:23 AM
Irish Jian	See Remarks	Jun 05 '26	Sale	1.30	3,737	4,854	377,533	Jun 10 11:21 AM
Wein Matthew	See Remarks	Jun 05 '26	Sale	1.30	558	725	126,491	Jun 10 11:19 AM
Wapnick Pamela	Chief Financial Officer	Mar 05 '26	Sale	1.60	1,581	2,530	187,375	Mar 09 05:16 PM
Wein Matthew	See Remarks	Mar 05 '26	Sale	1.60	482	771	114,549	Mar 09 05:16 PM
Irish Jian	Chief Executive Officer	Mar 05 '26	Sale	1.60	1,607	2,571	333,770	Mar 09 05:15 PM
Thomas Brian C.	Director	Dec 05 '25	Sale	1.77	3,830	6,786	2,510,960	Dec 08 01:56 PM
Wein Matthew	See Remarks	Dec 05 '25	Sale	1.77	199	353	115,031	Dec 08 01:51 PM
Wapnick Pamela	Chief Financial Officer	Dec 05 '25	Sale	1.77	1,576	2,793	188,956	Dec 08 01:49 PM
Irish Jian	Chief Executive Officer	Dec 05 '25	Sale	1.77	1,602	2,839	563,839	Dec 08 01:38 PM

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Ph.D.Dr. Jian Irish M.B.A.

Chief Financial OfficerMs. Pamela M. Wapnick M.B.A.

Gen-er-al Coun-selMr. Matthew L. Wein J.D.

Co-Founder & Member of Scientific Advisory BoardDr. Joseph Knowles M.D.

Senior Vice Pres-i-dent of Tech-ni-cal Devel-op-ment & Oper-a-tionsMr. Mark Leonard

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

MGX

Metagenomi Therapeutics Inc

Upgrade your Finviz experience

All the Features.
Half the Price.